The institution logo for Kenvue Inc. Johnson & Johnson's consumer-health concern is displayed during the company's archetypal nationalist offering astatine the New York Stock Exchange connected May 4, 2023.
Brendan Mcdermid | Reuters
Kimberly-Clark said connected Monday it volition bargain Tylenol-maker Kenvue successful a cash-and-stock woody valued astatine astir $48.7 billion, to make 1 of the biggest user wellness goods companies successful the United States.
Shares of Kenvue were up 18% successful premarket trading, portion Kimberly-Clark's shares were down 12.5%.
Kenvue has been nether a strategical review, enactment shake-up, and mounting litigation risks. It came nether caller scrutiny pursuing President Donald Trump's comments linking its fashionable symptom medicine Tylenol to autism.
The woody volition bring unneurotic brands including Neutrogena, Huggies and Kleenex nether a user wellness and idiosyncratic attraction institution with expected combined yearly revenues of astir $32 billion.
Sources successful June told Reuters the strategical reappraisal of its operations could see a merchantability oregon breakup of the institution that had been spun disconnected from healthcare conglomerate Johnson & Johnson successful 2023.
Kenvue's shareholders volition person $3.50 per stock and 0.15 Kimberly-Clark shares for each Kenvue stock held. That implies a per-share woody worth of $21.01, oregon an equity worth of $40.32 billion, according to Reuters calculations.
English (US) ·